FDA Issues Final Lead-In-Lipstick Report, Postpones Decision On Cosmetic Lead Limits

FDA’s expanded survey of lead levels in lipstick examined 400 products on the market, finding an average amount of 1.11 ppm, comparable with its initial test of 20 lipsticks, which averaged 1.07 ppm lead content.

FDA’s final report on lead in lipstick finds levels consistent with its 2009 investigation and emphasizes that the agency does not believe the lead content in currently marketed lipstick presents a safety concern to consumers.

In a Dec. 5 update to a question-and-answer page regarding lead in lipstick on its website, FDA published the results...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

Kennedy Appears Ill-Informed On Major Pharma Priorities, Creating Unique Lobbying Dynamics

 

Health and Human Services secretary made incorrect statements about the status of key industry priorities at a recent House hearing, which actually may be a good thing for drug sponsors.

Lupin Goes For Growth With Indian Consumer Health Spin-Off

 
• By 

With annual sales approaching $20m, LupinLife Consumer Healthcare has ambitious growth plans for the Indian OTC market.

L’Oréal Plans Purchase Of Color Wow Brand

 

L’Oréal has signed an agreement to acquire the Color Wow professional styling brand for an undisclosed price.